Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female.~* Meet diagnostic criteria for dysphagia symptoms using the NOMAS and a VFSS.~* Infants with intraventricular hemorrhage (IVH) and hypoxic events can be included.~* Infants taking less than 5-10% of target volume by mouth between the ages of 36-42 weeks PCA.~* Multiple swallows to clear bolus following suck that includes a desaturation \<80% and bradycardia \<80 bpm.~* Apnea spells during feeds.~* Aspiration or penetration by VFSS~Exclusion Criteria:~* Known neurologic or neurodegenerative disorders.~* Chromosomal anomalies and syndromes.~* Cleft lip or palate.~* Birth defects.~* Unresolved cutaneous rash at the area of electrode placement.~* Medical condition that is a contraindication to NMES.

- Gender: ALL
- Minimum Age: 36 Weeks
- Maximum Age: 42 Weeks
- Healthy Volunteers: f

Study Arms:
- VitalStim (Type: EXPERIMENTAL): This group will be assigned to the active VitalStim unit.
- Sham VitalStim (Type: SHAM_COMPARATOR): This group will be assigned to the sham VitalStim unit.

Based on this trial design, predict the completion outcome and termination type (if applicable).